Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Trichorhinophalangeal syndrome (TRPS) is an autosomal dominant skeletal dysplasia caused by heterozygous variants in the TRPS1 gene, characterized by sparse hair, craniofacial dysmorphism, and cone-shaped epiphyses. The disease spectrum spans three subtypes (TRPS I–III) with overlapping features of pear-shaped nose, thin upper lip vermilion, and brachydactyly ([PMID:23691375]).
Over 50 probands from at least 17 unrelated families harbor truncating, missense, and frameshift TRPS1 variants, including recurrent nonsense mutations c.2086C>T (p.Arg696Ter) and c.1198C>T (p.Gln400Ter) observed de novo in TRPS I ([PMID:23691375], [PMID:30458885]). Frameshift variants such as c.2854_2858del (p.Asn952ArgfsTer2) segregate across four generations in a Cypriot kindred ([PMID:36093893]), and exon-6 missense changes (e.g., c.2893C>T (p.Arg965Cys)) impair nuclear localization, defining a genotype-phenotype correlation ([PMID:14560312], [PMID:17854380]). Large deletions encompassing TRPS1–EXT1 underlie TRPS II ([PMID:26269715], [PMID:36598218]).
Segregation analyses document at least eight additional affected relatives carrying familial TRPS1 variants, confirming autosomal dominant inheritance with high penetrance in multiple pedigrees ([PMID:30458885], [PMID:36093893]). The variant spectrum includes 15 truncating, 7 missense, 3 frameshift, and multiple whole-gene deletions or microdeletions, indicating loss-of-function as the primary pathogenic mechanism.
Functional assays demonstrate that TRPS1 haploinsufficiency disrupts transcriptional repression of STAT3 and RUNX2, impairs chondrocyte proliferation and apoptosis, and accelerates perichondrial mineralization in mouse growth plates, recapitulating human skeletal defects ([PMID:17997399], [PMID:18424451]). Immunohistochemical studies reveal markedly reduced TRPS1 expression in patient hair follicles, with consequent upregulation of phospho-Stat3 signaling ([PMID:23451857]). Palatal fusion assays in Trps1-null mice show cleft palate due to failure of epithelial chondroitin sulfate proteoglycan and TGF-β3 expression, underscoring a developmental role in craniofacial skeletogenesis ([PMID:31130868]).
To date, no studies have refuted the TRPS1–TRPS association, and somatic TRPS1 alterations in other diseases (e.g., endometrial cancer) do not phenocopy TRPS syndrome. The concordance of extensive genetic, segregation, and functional data fulfills ClinGen criteria for a Definitive gene‐disease association.
Key Take-home: TRPS1 genetic testing is essential for diagnosis and management of trichorhinophalangeal syndrome due to its autosomal dominant inheritance, broad variant spectrum, and clear mechanistic insights.
Gene–Disease AssociationDefinitive
Genetic EvidenceStrong25 unique TRPS1 variants including truncating, missense, and frameshifts in >50 probands across diverse families ([PMID:23691375], [PMID:36598218]) Functional EvidenceStrongMouse models recapitulate TRPS phenotype; nuclear localization and transcriptional repression assays confirm haploinsufficiency ([PMID:17997399], [PMID:31130868]) |